BREAKING NEWS: Is Insuring Your Identity Against Fraud Worth It?

Bloomberg - Home Search
Celgene Corp (CELG:US)
update Mar 2
120.31 -1.22 (-1.00%)
TODAY
High 122.78
Low 120.20
Open 122.62
Volume 5197903
Time Mar 2
intra-day chart
52 WEEK SUMMARY
High 125.45
Low 66.85
P/E 47.03
Return +50.12%
Mkt Cap 96.319 B
one year chart
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.